*Corresponding author:
Chiragkumar J Gohil, Department of Pharmaceutical Chemistry, Shree Laxminarayan Dev College of Pharmacy, Bholav, Bharuch, IndiaReceived: October 16, 2017; Published: October 24, 2017
DOI: 10.26717/BJSTR.2017.01.000460
To view the Full Article Peer-reviewed Article PDF
epresent a complex of diseases with identical clinical and epidemiological diversity. They depending on clinical symptoms having 3 different species: cutaneous Leishmaniasis, visceral leishmaniasis, mucocutaneous leishmaniasis. The diff stage involvement to produce infection. This infection diagnosis is the depending on the severity of the diease. The cutaneous leishmaniasis is a not more dangerous compare two other types of leishmaniasis. The diff techniques are available for diagnosis purpose. The efficacy of treatment varies with the type of infecting species and resistance pattern. The persistent lack of vaccine against human leishmaniasis is a result of the poor investment in this neglected parasitosis.
Keywords : Leishmaniasis; Parasite; Cutaneous Leishmaniasis; Visceral leishmaniasis; Muco cutaneous leishmaniasis
Abstract| Introduction| Symptoms/Pathology| Life Cycle| Diagnose| Treatment| References|